| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
95,496 |
94,543 |
$7.90M |
| 0750 |
|
6,290 |
6,237 |
$4.23M |
| 0360 |
|
2,519 |
1,310 |
$1.10M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
63,793 |
62,708 |
$900K |
| Z7502 |
|
14,706 |
14,548 |
$547K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,900 |
4,847 |
$215K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,319 |
8,125 |
$194K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,710 |
22,530 |
$165K |
| 80053 |
Comprehensive metabolic panel |
43,872 |
43,387 |
$137K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,969 |
48,434 |
$116K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
11,192 |
10,772 |
$107K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,720 |
16,460 |
$71K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,458 |
2,455 |
$60K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
14,916 |
14,388 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,530 |
2,511 |
$30K |
| 83690 |
|
13,249 |
13,161 |
$26K |
| 86141 |
|
7,842 |
7,731 |
$18K |
| Z7610 |
|
2,558 |
1,433 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,283 |
2,269 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
922 |
905 |
$12K |
| 81001 |
|
12,516 |
12,373 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
3,461 |
1,784 |
$9K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,111 |
2,994 |
$5K |
| 81003 |
|
7,201 |
7,148 |
$5K |
| J3490 |
Unclassified drugs |
78,098 |
41,947 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,031 |
5,833 |
$4K |
| 84484 |
|
1,835 |
1,472 |
$4K |
| 99199 |
Unlisted special service, procedure or report |
72 |
70 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
99 |
50 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,214 |
1,205 |
$3K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,058 |
1,053 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,299 |
2,284 |
$2K |
| 43235 |
|
567 |
561 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
78 |
77 |
$2K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
421 |
416 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,400 |
1,367 |
$850.59 |
| 90715 |
|
83 |
65 |
$798.54 |
| 76000 |
|
105 |
103 |
$793.30 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
312 |
311 |
$747.30 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,670 |
7,062 |
$723.47 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
294 |
293 |
$711.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,836 |
7,239 |
$608.45 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
54 |
27 |
$596.14 |
| 71045 |
Radiologic examination, chest; single view |
254 |
131 |
$553.56 |
| 99070 |
|
137 |
92 |
$533.66 |
| J2704 |
Injection, propofol, 10 mg |
1,463 |
1,431 |
$525.78 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,325 |
1,253 |
$512.17 |
| 36415 |
Collection of venous blood by venipuncture |
22,516 |
22,055 |
$511.85 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
713 |
692 |
$410.31 |
| 84702 |
|
188 |
184 |
$377.24 |
| 72100 |
|
51 |
26 |
$347.60 |
| 82962 |
|
752 |
700 |
$339.73 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
128 |
126 |
$272.81 |
| 85610 |
|
232 |
230 |
$256.94 |
| 0510 |
|
823 |
823 |
$246.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,805 |
1,762 |
$245.25 |
| 73630 |
|
24 |
13 |
$198.77 |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
12 |
12 |
$188.75 |
| 83880 |
|
26 |
26 |
$180.90 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
565 |
555 |
$163.65 |
| 0272 |
|
993 |
966 |
$145.20 |
| 85027 |
|
70 |
70 |
$122.47 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
37 |
37 |
$118.35 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
98 |
98 |
$112.16 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
56 |
55 |
$87.60 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
145 |
142 |
$79.48 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$71.40 |
| 83605 |
|
52 |
51 |
$59.52 |
| 87210 |
|
27 |
27 |
$58.51 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,391 |
2,362 |
$52.07 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
67 |
67 |
$50.20 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$31.17 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$31.07 |
| 81025 |
|
18 |
18 |
$23.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
304 |
298 |
$22.83 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
24 |
24 |
$14.82 |
| 85730 |
|
13 |
13 |
$8.50 |
| J1644 |
Injection, heparin sodium, per 1000 units |
177 |
177 |
$4.73 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
127 |
127 |
$3.25 |
| 0072A |
|
1,758 |
1,758 |
$0.00 |
| 0710 |
|
1,329 |
1,310 |
$0.00 |
| 0370 |
|
7,527 |
7,457 |
$0.00 |
| 0081A |
|
400 |
399 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,755 |
1,750 |
$0.00 |
| 0052A |
|
1,159 |
1,159 |
$0.00 |
| 0051A |
|
797 |
797 |
$0.00 |
| 0636 |
|
496 |
471 |
$0.00 |
| 90686 |
|
4,124 |
2,060 |
$0.00 |
| 0082A |
|
427 |
427 |
$0.00 |
| 0154A |
|
309 |
309 |
$0.00 |
| 0111A |
|
90 |
90 |
$0.00 |
| 0771 |
|
80 |
80 |
$0.00 |
| 90716 |
|
252 |
126 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
66 |
66 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
300 |
278 |
$0.00 |
| 0074A |
|
311 |
311 |
$0.00 |
| 0064A |
|
3,791 |
3,791 |
$0.00 |
| 90647 |
|
226 |
113 |
$0.00 |
| 90480 |
|
417 |
417 |
$0.00 |
| 90723 |
|
52 |
26 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
92 |
92 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |
| 0271 |
|
50 |
50 |
$0.00 |
| 0112A |
|
80 |
80 |
$0.00 |
| 90680 |
|
53 |
26 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
15 |
15 |
$0.00 |
| 80320 |
|
24 |
24 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
76 |
76 |
$0.00 |
| 90649 |
|
50 |
50 |
$0.00 |
| 0071A |
|
7,729 |
7,195 |
$0.00 |
| 0054A |
|
6,373 |
6,373 |
$0.00 |
| 91320 |
|
29 |
29 |
$0.00 |
| 90633 |
|
324 |
162 |
$0.00 |
| 0003A |
|
444 |
444 |
$0.00 |
| 91322 |
|
375 |
375 |
$0.00 |
| 0004A |
|
6,215 |
6,214 |
$0.00 |
| 0124A |
|
2,078 |
2,078 |
$0.00 |
| 0083A |
|
48 |
48 |
$0.00 |
| 0013A |
|
239 |
239 |
$0.00 |
| 90707 |
|
144 |
72 |
$0.00 |
| 90700 |
|
68 |
34 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
31 |
31 |
$0.00 |
| 90670 |
|
220 |
110 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$0.00 |
| 0073A |
|
35 |
35 |
$0.00 |
| 99152 |
|
13 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
30 |
30 |
$0.00 |
| 90713 |
|
24 |
12 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
38 |
38 |
$0.00 |
| 0034A |
|
13 |
13 |
$0.00 |
| 99188 |
|
14 |
14 |
$0.00 |